Literature DB >> 24666474

Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases.

Steven D Allen1, Matthew G Wallis, Rosie Cooke, Anthony J Swerdlow.   

Abstract

PURPOSE: To retrospectively review diagnostic mammography in women diagnosed with breast cancer who previously had mantle field radiation therapy for Hodgkin disease in England and Wales over a period of 30 years.
MATERIALS AND METHODS: From a national cohort study of 5002 women treated with supradiaphragmatic radiation therapy when they were younger than 36 years (mean, 22.1 years) during 1956-2003, 392 patients developed breast cancer. With ethics committee approval and informed consent, mammograms were obtained that showed 230 tumors in 222 (56.6%) patients from 95 hospitals, and the size and appearance of each carcinoma was recorded by two breast radiologists. Comparison was made with a historical report of more than 1000 general-population breast cancers by using Pearson χ(2) test.
RESULTS: Thirty-eight tumors were occult on mammograms. Mean tumor maximum diameter was 12.3 mm (n = 81) on oblique view. The quadrant distribution of the tumors was significantly different (P < .001) from the historic controls, and chest radiation therapy patients had a greater proportion of tumors in the upper outer (66.9% [107 of 160] vs 48.7% [385 of 784]) and, to a lesser extent, lower inner (10.6% [17 of 160] vs 7.8% [61 of 784]) quadrants. The dominant radiologic feature was of an irregular mass (56.8% [109 of 192]) followed by microcalcifications (25.0% [48 of 192]).
CONCLUSION: This study suggests that in patients who previously underwent mantle radiation therapy for Hodgkin disease, breast cancers are more commonly seen within the upper outer quadrants than are cancers in the general population. Poorly defined masses were the most common appearance. © RSNA, 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24666474     DOI: 10.1148/radiol.14131789

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM.

Authors:  Giovanna Mariscotti; Paolo Belli; Daniela Bernardi; Beniamino Brancato; Massimo Calabrese; Luca A Carbonaro; Beatrice Cavallo-Marincola; Francesca Caumo; Paola Clauser; Laura Martinchich; Stefania Montemezzi; Pietro Panizza; Federica Pediconi; Alberto Tagliafico; Rubina M Trimboli; Chiara Zuiani; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-07-12       Impact factor: 3.469

2.  T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.

Authors:  Jiachen Wang; Kefeng Shen; Wei Mu; Weigang Li; Meilan Zhang; Wei Zhang; Zhe Li; Tong Ge; Zhoujie Zhu; Shangkun Zhang; Caixia Chen; Shugang Xing; Li Zhu; Liting Chen; Na Wang; Liang Huang; Dengju Li; Min Xiao; Jianfeng Zhou
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

3.  Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.

Authors:  Nicola S Russell; Inge M Krul; Anna M van Eggermond; Berthe M P Aleman; Rosie Cooke; Susanne Kuiper; Steven D Allen; Matthew G Wallis; Damien Llanas; Ibrahima Diallo; Florent de Vathaire; Susan A Smith; Michael Hauptmann; Annegien Broeks; Anthony J Swerdlow; Flora E Van Leeuwen
Journal:  Clin Transl Radiat Oncol       Date:  2017-10-24

Review 4.  Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference.

Authors:  David Chelmow; Mark D Pearlman; Amy Young; Laura Bozzuto; Sandra Dayaratna; Myrlene Jeudy; Mallory E Kremer; Dana Marie Scott; Julia Sage O'Hara
Journal:  Obstet Gynecol       Date:  2020-06       Impact factor: 7.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.